Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review-Reference-Cited by-同舟云学术

Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review

Published:2020-05 Issue:1 Volume:7 Page:
ISSN:2045-0885
Container-title:Melanoma Management
language:en
Short-container-title:Melanoma Management

Author:

Miller Rachael¹,Walker Sophie¹,Shui Irene²,Brandtmüller Agnes³,Cadwell Kevin¹,Scherrer Emilie²

Affiliation:

1. PHMR Ltd, Berkeley Works, Berkley Grove, Camden Town, London, UK

2. Merck & Co., Inc., Kenilworth, NJ 07033, USA

3. MSD: Pharma Hungary Ltd, Budapest, 1095, Hungary

Abstract

Aim: Management of cutaneous melanoma (CM) is continually evolving with adjuvant treatment of earlier stage disease. The aim of this review was to identify published epidemiological data for stages II–III CM. Materials & methods: Systematic searches of Medline and Embase were conducted to identify literature reporting country/region-specific incidence, prevalence, survival or mortality outcomes in stage II and/or III CM. Screening was carried out by two independent reviewers. Results & conclusion: Of 41 publications, 14 described incidence outcomes (incidence rates per stage were only reported for US and Swedish studies), 33 reported survival or mortality outcomes and none reported prevalence data. This review summarizes relevant data from published literature and highlights an overall paucity of epidemiological data in stages II and III CM.

Publisher

Future Medicine Ltd

Subject

Dermatology,Oncology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/mmt-2019-0022

Reference58 articles.

1. Epidemiology of Melanoma

2. International Agency for Research on Cancer (IARC), WHO. Cancer incidence in five continents, CI5plus: IARC CancerBase No. 9 (2018). http://ci5.iarc.fr/CI5plus/Default.aspx

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Property and Cytotoxic Effect Showing Antiproliferative Potency in Human Melanoma Cell Lines (A375) of Combretum racemosum P. Beauv. Leaf and Root Extracts Used in Benin;Antioxidants;2023-12-22

2. Fatty Acid Metabolism-Related lncRNAs are Potential Biomarkers for Predicting Prognoses and Immune Responses in Patients with Skin Cutaneous Melanoma;Clinical, Cosmetic and Investigational Dermatology;2023-12

3. Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albumin;European Journal of Pharmaceutical Sciences;2023-10

4. Caffeine reduces viability, induces apoptosis, inhibits migration and modulates the CD39/CD73 axis in metastatic cutaneous melanoma cells;Purinergic Signalling;2023-09-28

5. COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma;Future Oncology;2023-09